← All trials
NCT03457324
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 8, 2018
- Primary completion
- Jun 30, 2021
- Completion date
- Jun 30, 2021
- First posted
- Mar 7, 2018
- Last posted
- Aug 19, 2020
- Enrollment
- 392
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hong Kong Baptist UniversityLead sponsor
- Chinese University of Hong KongCollaborator
- Chinese University of Hong KongOverall official - principal investigator
- Hong Kong Baptist UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.